NDI draft guidance

FDA prevails over Hi-Tech on DMAA, but ruling could open door on synthetic botanicals

iStock

A federal district court judge in Atlanta has ruled in favor of FDA in its case against Hi-Tech Pharmaceuticals over its use of DMAA. But the ruling potentially weakens agency’s stance on the question of synthetic versions of constituents of botanicals.

AHPA, CRN suggest tweaks, wholesale overhauls of manufacturing regs

AHPA, CRN suggest tweaks, wholesale overhauls of manufacturing regs

Acacia rigidula still popping up on market

Acacia rigidula still popping up on market

PEAs harder to control than were steroids, experts say

PEAs harder to control than were steroids, experts say

© iStock/Pinkypills

FDA continues to ‘carefully review’ vinpocetine comments

NDI guidance would over regulate, weaken supplement industry, Jarrow asserts

NDI guidance would over regulate, weaken supplement industry, Jarrow asserts

© iStock/Jezperklauzen

IPA recommends expanded grandfathered list for probiotics

Sen McCaskill calls on FDA to quickly finalize NDI guidance

Sen McCaskill calls on FDA to quickly finalize NDI guidance

© iStock / bernie_moto

UNPA brands FDA's finished product focus in NDI guidance as unworkable and unlawful

NPA urges FDA to back off in applying food additive standards

NPA urges FDA to back off in applying food additive standards

More NDI draft guidance